Shopping Cart
- Remove All
- Your shopping cart is currently empty
Cibisatamab is a T-cell bispecific antibody that acts as a T-cell splicer.Cibisatamab targets carcinoembryonic antigen (CEA) on cancer cells and CD3 on T-cells, and triggers T-cell killing when the CEA on the surface of the cancer cells ranges from intermediate to high levels.Cibisatamab may be used to study solid cancers such as colorectal cancer.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $562 | In Stock | |
5 mg | $993 | In Stock | |
10 mg | $1,650 | In Stock | |
25 mg | $2,460 | In Stock | |
50 mg | $3,320 | In Stock |
Description | Cibisatamab is a T-cell bispecific antibody that acts as a T-cell splicer.Cibisatamab targets carcinoembryonic antigen (CEA) on cancer cells and CD3 on T-cells, and triggers T-cell killing when the CEA on the surface of the cancer cells ranges from intermediate to high levels.Cibisatamab may be used to study solid cancers such as colorectal cancer. |
Molecular Weight | 191.1 kDa |
Cas No. | 1855925-27-7 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.